Effects of a high-dose, fast tapering buprenorphine detoxification program on symptom relief and treatment retention

Journal of Psychoactive Drugs

Volumn 36, Issue 2, 2004, Pages 273-277

  Palmstierna, Tom ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Buprenorphine; Heroin addiction; Opiate withdrawal syndrome; Treatment retention

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUPRENORPHINE; CLONIDINE; DEXTROPROPOXYPHENE; DIAMORPHINE; NARCOTIC ANALGESIC AGENT; OPIATE; OPIATE AGONIST; OPIATE ANTAGONIST;

ADULT; ARTICLE; CLINICAL ARTICLE; DETOXIFICATION; DRUG DEPENDENCE TREATMENT; DRUG DETOXIFICATION; DRUG MEGADOSE; HEROIN DEPENDENCE; HUMAN; MALE; OPIATE ADDICTION; SYMPTOMATOLOGY; TREATMENT OUTCOME; WITHDRAWAL SYNDROME;

EID: 3843102646     PISSN: 02791072     EISSN: 21599777     Source Type: Journal    
DOI: 10.1080/02791072.2004.10399738     Document Type: Article

References (20)

1. Clark, N.C.; Lintzeris, N. & Muhleisen, P.J. 2002. Severe opiate withdrawal in a heroin user precipitated by a massive buprenorphine dose. Medical Journal of Austria 176 (4): 166-67.
2. Comer, S.D.; Collins, E.D. & Fischman, M.W. 2001. Buprenorphine sublingual tablets: Effects on IV heroin self-administration by humans. Psychopharmacology (Berlin) 154 (1): 28-37.
3. Diamant, K.; Fischer, G.; Schneider, C.; Lenzinger, E.; Pezawas, L.; Schindler, S. & Eder, H. 1998. Outpatient opiate detoxification treatment with buprenorphine. Preliminary investigation. European Addiction Research 4 (4): 198-202.
4. Gold, M.S.; Pottash, A.L. & Extein I. 1982. Clonidine: Inpatient studies from 1978 to 1981. Journal of Clinical Psychiatry 43: 35-38.
5. Gold, M.S.; Redmond, D.E. & Kleber, H.D. 1978. Clonidine blocks acute opiate-withdrawal symptoms. Lancet ii: 599-602.
6. Gossop, M.; Griffiths, P.; Bradley, B. & Strang, J. 1989. Opiate withdrawal symptoms in response to I 0-day and 21 -day methadone withdrawal programmes. British Journal of Psychiatry 154: 360-63.
7. Handelsman, L.; Cochrane, K.J.; Aronson, M.J.; Ness, R.; Rubinstein, K.J. & Kanof, P.D. 1987. Two new rating scales for opiate withdrawal. American Journal of Drug Alcohol Abuse 3: 293-308.
8. Himmelsbach, C.K. 1941.The morphine abstinence syndrome, its nature and treatment. Annals of Internal Medicine 15: 829-39.
9. Kleber, H.D. 1999. Opioids: Detoxification. In: M. Galanter & H.D. Kleber (Ed.) Textbook of Substance Abuse Treatment. Washington, D.C.: American Psychiatric Press Inc.
10. Kleber, H.D.; Topazian, M.; Gaspari, J.; Riordan, C.E. & Kosten, T. 1987. Clonidine and naltrexone in the outpatient treatment ofheroin withdrawal. American Journal of Drug and Alcohol Abuse 13: 117.
11. Kutz, I. & Reznik, V. 2001. Rapid heroin detoxification using a single high dose of buprenorphine. Journal of Psychoactive Drugs 33 (2): 191-93.
12. Liu, Z.M.; Cai, Z.J.; Wang, X.P.; Ge, Y. & Li, CM. 1997. Rapid detoxification of heroin dependence by buprenorphine. Zhongguo YaoLiXueBao 18(2): 112-14.
13. Mello, N.K. & Mendelson, J.H. 1980. Buprenorphine suppresses heroin use by heroin addicts. Science 207: 657-59.
14. O'Connor, P.G.; Carroll, K.M.; Shi, J.M.; Schottenfeld, R.S.; Kosten, T.R. & Rounsaville, B.J. 1997. Three methods of opioid detoxification in a primary care setting. A randomised trial. Annals of Internal Medicine 127: 526-30.
15. Petry, N.M.; Bickel, W.K. & Badger, G.J. 2001. Examining the limits of the buprenorphine interdosing interval: Daily, every-third-day and every-fifth-day dosing regimens. Addiction 96 (6): 823-34.
16. Schanda, H.; Presslich, O. & Hermann, P. 1983. [Clonidine for the treatment of heroin withdrawal syndrome].[Article in German]. Wiener Klinische Wochenschrift 95: 569-72.
17. Tennant, F.S.; Russell, B.A.; Casas, S.K. & Bleich, R.N. 1975. Heroin detoxification. A comparison of propoxyphene and methadone. Journal of the American Medical Association 232: 1 19-22.
18. Umbricht, A.; Montoya, I.D.; Hoover, D.R.; Demuth, K.L.; Chiang, C.T. & Preston, K.L. 1999. Naltrexone shortened opioid detoxification with buprenorphine. Drug and Alcohol Dependency 56: 181-90.
19. Wang, R.I.; Kochar, C.; Hasegawa, A.T. & Roh, B.L. 1981. Propoxyphene napsylate compared to methadone for opiate dependence. Psychopharmacology (Berlin) 75: 335-38.
20. White, R.; Alcorn, R. & Feinmann, C. 2001. Two methods ofcommunity detoxification from opiates: An open-label comparison of lofexidine and buprenorphine. Drug and Alcohol Dependency 65 (1): 77-83.